Rallye in Biontech shares extends as European Medicines Agency has accelerated approval process for a Covid-19 vaccine developed by Germany's BioNTech & Pfizer, to allow for the rapid authorisation of the shot as soon as safety data from its trial allows. #CoronavirusOutbreak# #Eurozone# #StockMarket#
Disclaimer: The views expressed are solely those of the author and do not represent the official position of Followme. Followme does not take responsibility for the accuracy, completeness, or reliability of the information provided and is not liable for any actions taken based on the content, unless explicitly stated in writing.
No comments yet. Be the first to share your view.